Stock listing
BOATS:SNGX Soligenix, Inc. Stock
US listing (BOATS) of Soligenix, Inc. · home listing NASDAQ:SNGX
Follow Soligenix, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:SNGX
$0.356 USD -0.013 (-3.6%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:SNGX
- Day range
- $0.355 – $0.378 USDOct 30, 2026
- Volume
- 69,423 sharesOct 30, 2026
- Market cap
- $7.75M USDAt the close on Oct 30, 2026 · price × 21.77M shares outstanding
- 52-week range
- $0.280 – $1.700 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $74,111 USDMedian day 132,000 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:SNGX · Home | $0.356 USD | -0.013 (-3.6%) | 69,423 | $0.378 | $0.378 | $0.355 | $0.369 | Close on Oct 30, 2026 |
| LSE:0A6I | $0.368 USD | +0.008 (+2.1%) | 11,831 | $0.350 | $0.375 | $0.337 | $0.360 | Close on Oct 27, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:SNGX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.356 | -0.013 | -3.6% | $0.378 | $0.378 | $0.355 | 69,423 | |
| $0.369 | -0.006 | -1.5% | $0.376 | $0.378 | $0.368 | 36,555 | |
| $0.375 | +0.012 | +3.3% | $0.351 | $0.375 | $0.351 | 62,279 | |
| $0.363 | +0.013 | +3.7% | $0.350 | $0.370 | $0.350 | 74,407 | |
| $0.350 | -0.020 | -5.4% | $0.369 | $0.371 | $0.350 | 47,606 | |
| $0.370 | +0.010 | +2.8% | $0.350 | $0.370 | $0.340 | 127,000 | |
| $0.360 | +0.010 | +2.9% | $0.370 | $0.370 | $0.350 | 131,600 | |
| $0.350 | 0.000 | 0.0% | $0.340 | $0.370 | $0.340 | 69,100 | |
| $0.350 | +0.010 | +2.9% | $0.340 | $0.360 | $0.340 | 81,200 | |
| $0.340 | -0.010 | -2.9% | $0.340 | $0.350 | $0.340 | 69,700 | |
| $0.350 | -0.010 | -2.8% | $0.360 | $0.360 | $0.350 | 217,700 | |
| $0.360 | +0.020 | +5.9% | $0.340 | $0.360 | $0.340 | 163,200 | |
| $0.340 | +0.010 | +3.0% | $0.320 | $0.350 | $0.320 | 148,200 | |
| $0.330 | -0.020 | -5.7% | $0.350 | $0.370 | $0.330 | 267,400 | |
| $0.350 | -0.010 | -2.8% | $0.360 | $0.370 | $0.350 | 61,800 | |
| $0.360 | +0.010 | +2.9% | $0.350 | $0.370 | $0.350 | 114,500 | |
| $0.350 | 0.000 | 0.0% | $0.360 | $0.360 | $0.350 | 120,200 | |
| $0.350 | -0.010 | -2.8% | $0.360 | $0.360 | $0.350 | 62,800 | |
| $0.360 | 0.000 | 0.0% | $0.360 | $0.360 | $0.360 | 185,600 | |
| $0.360 | -0.010 | -2.7% | $0.360 | $0.370 | $0.360 | 107,900 | |
| $0.370 | +0.010 | +2.8% | $0.370 | $0.370 | $0.360 | 146,500 | |
| $0.360 | 0.000 | 0.0% | $0.360 | $0.370 | $0.360 | 45,300 | |
| $0.360 | -0.010 | -2.7% | $0.370 | $0.370 | $0.360 | 90,300 | |
| $0.370 | -0.010 | -2.6% | $0.380 | $0.380 | $0.360 | 406,600 | |
| $0.380 | 0.000 | 0.0% | $0.380 | $0.380 | $0.380 | 135,000 | |
| $0.380 | -0.010 | -2.6% | $0.390 | $0.390 | $0.380 | 72,700 | |
| $0.390 | 0.000 | 0.0% | $0.380 | $0.390 | $0.380 | 228,600 | |
| $0.390 | 0.000 | 0.0% | $0.390 | $0.390 | $0.380 | 372,700 | |
| $0.390 | +0.020 | +5.4% | $0.390 | $0.390 | $0.380 | 529,800 | |
| $0.370 | 0.000 | 0.0% | $0.380 | $0.380 | $0.370 | 341,300 | |
| $0.370 | -0.010 | -2.6% | $0.370 | $0.390 | $0.370 | 257,400 | |
| $0.380 | +0.020 | +5.6% | $0.360 | $0.400 | $0.360 | 971,500 | |
| $0.360 | 0.000 | 0.0% | $0.360 | $0.360 | $0.360 | 125,800 | |
| $0.360 | 0.000 | 0.0% | $0.360 | $0.370 | $0.360 | 288,300 | |
| $0.360 | 0.000 | 0.0% | $0.370 | $0.370 | $0.360 | 98,400 | |
| $0.360 | 0.000 | 0.0% | $0.360 | $0.370 | $0.360 | 147,200 | |
| $0.360 | -0.010 | -2.7% | $0.360 | $0.370 | $0.360 | 124,100 | |
| $0.370 | -0.010 | -2.6% | $0.380 | $0.390 | $0.370 | 126,400 | |
| $0.380 | 0.000 | 0.0% | $0.380 | $0.390 | $0.380 | 95,200 | |
| $0.380 | 0.000 | 0.0% | $0.380 | $0.380 | $0.380 | 119,100 | |
| $0.380 | 0.000 | 0.0% | $0.390 | $0.390 | $0.380 | 59,900 | |
| $0.380 | 0.000 | 0.0% | $0.380 | $0.390 | $0.370 | 90,000 | |
| $0.380 | 0.000 | 0.0% | $0.370 | $0.390 | $0.370 | 122,200 | |
| $0.380 | 0.000 | 0.0% | $0.380 | $0.390 | $0.360 | 400,300 | |
| $0.380 | 0.000 | 0.0% | $0.380 | $0.390 | $0.370 | 139,500 | |
| $0.380 | 0.000 | 0.0% | $0.380 | $0.390 | $0.380 | 379,200 | |
| $0.380 | -0.030 | -7.3% | $0.400 | $0.400 | $0.380 | 590,900 | |
| $0.410 | +0.010 | +2.5% | $0.410 | $0.410 | $0.400 | 218,100 | |
| $0.400 | 0.000 | 0.0% | $0.410 | $0.410 | $0.400 | 311,100 | |
| $0.400 | +0.020 | +5.3% | $0.380 | $0.420 | $0.380 | 989,200 | |
| $0.380 | 0.000 | 0.0% | $0.380 | $0.390 | $0.380 | 94,000 | |
| $0.380 | -0.020 | -5.0% | $0.390 | $0.390 | $0.380 | 106,500 | |
| $0.400 | +0.020 | +5.3% | $0.380 | $0.400 | $0.380 | 133,900 | |
| $0.380 | -0.020 | -5.0% | $0.390 | $0.390 | $0.380 | 113,200 | |
| $0.400 | +0.020 | +5.3% | $0.380 | $0.400 | $0.380 | 333,500 | |
| $0.380 | -0.010 | -2.6% | $0.390 | $0.390 | $0.380 | 135,800 | |
| $0.390 | 0.000 | 0.0% | $0.380 | $0.400 | $0.380 | 127,100 | |
| $0.390 | +0.010 | +2.6% | $0.380 | $0.390 | $0.380 | 95,100 | |
| $0.380 | -0.010 | -2.6% | $0.400 | $0.400 | $0.380 | 144,700 | |
| $0.390 | +0.010 | +2.6% | $0.380 | $0.400 | $0.380 | 131,700 | |
| $0.380 | 0.000 | 0.0% | $0.380 | $0.390 | $0.380 | 132,300 | |
| $0.380 | 0.000 | 0.0% | $0.390 | $0.400 | $0.380 | 164,400 | |
| $0.380 | 0.000 | 0.0% | $0.380 | $0.380 | $0.380 | 249,200 | |
| $0.380 | +0.010 | +2.7% | $0.380 | $0.390 | $0.370 | 197,400 | |
| $0.370 | -0.010 | -2.6% | $0.370 | $0.400 | $0.360 | 325,200 | |
| $0.380 | +0.020 | +5.6% | $0.370 | $0.380 | $0.350 | 248,600 |
- Ticker
- BOATS:SNGX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Jun 8, 2026
Soligenix Applying for Vaccine Development Funding for Bundibugyo Ebola Vaccine
Latest deck · Apr 8, 2026
Investor Presentation (April 2026)
Investor deck · 26 slides
Latest news
Soligenix Applying for Vaccine Development Funding for Bundibugyo Ebola Vaccine
Jun 8, 2026
Closed $0.42 (-4.5%) on Jun 8, 2026
Suitability of Vaccine Platform for Bundibugyo Virus, Cause of the Ebola Outbreak in Congo
May 26, 2026
Closed $0.51 (+30.8%) on May 26, 2026
Soligenix Announces Recent Updates and First Quarter 2026 Financial Results
May 8, 2026
Closed $0.29 (-6.5%) on May 8, 2026
Soligenix Announces Interim Results from the Phase 3 FLASH2 Trial Evaluating HyBryte™ in Treatment of Cutaneous T-Cell Lymphoma
Apr 28, 2026
Closed $0.42 (-70.4%) on Apr 28, 2026
Positive Clinical Results from HyBryte™ Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma Published in Oncology and Therapy
Apr 2, 2026
Closed $1.14 (-0.9%) on Apr 2, 2026
Soligenix Announces Recent Accomplishments and Year End 2025 Financial Results
Mar 31, 2026
Closed $1.18 (+6.3%) on Mar 31, 2026
Soligenix Receives Orphan Drug Designation from the European Commission for SGX945 for the Treatment of Behçet's Disease
Mar 26, 2026
Closed $1.21 (+0.8%) on Mar 26, 2026
Soligenix (SNGX) HyBryte Data To Be Presented At USCLC Workshop Ahead Of AAD Meeting
Mar 24, 2026
Closed $1.17 (-3.3%) on Mar 24, 2026
HyBryte™ Treatment Results to be Presented at US Cutaneous Lymphoma Consortium Annual Workshop 2026
Mar 23, 2026
Closed $1.21 (+0.8%) on Mar 23, 2026
Soligenix Announces HyBryte™ Clinical Summary Published in "Expert Opinion on Investigational Drugs"
Mar 19, 2026
Closed $1.22 (0.0%) on Mar 19, 2026
Decks
Investor Presentation (April 2026)
Investor deck · 26 slides · Apr 8, 2026
Investor Presentation (August 2025)
Investor deck · 26 slides · Aug 5, 2025
Investor Presentation (May 2025)
Investor deck · 24 slides · May 1, 2025
Investor Presentation (October 2024)
Investor deck · 24 slides · Oct 3, 2024
Soligenix, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 22 in the last 12 months · 191 in all · newest Jun 8, 2026 · oldest 2019
- Decks
- 29 decks · latest Apr 8, 2026
Where Soligenix, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:SNGX · Home listing | NASDAQ | United States | USD |
| BOATS:SNGX · This page | BOATS | United States | USD |
| gettex:DOA0 | gettex | Germany | EUR |
| LSE:0A6I | LSE | United Kingdom | USD |
| Munich:DOA0 | Munich | Germany | EUR |
Log in to ask 6ix AI your own questions about Soligenix, Inc.